Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neurofibromatosis 1 × Radiation × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 25 Glioblastoma 23 Rectal Neoplasms 22 Prostatic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 17 Breast Neoplasms 17 Pancreatic Neoplasms 16 Lung Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 14 Head and Neck Neoplasms 14 Neoplasms 12 Oropharyngeal Neoplasms 11 Neoplasm Metastasis 10 Esophageal Squamous Cell Carcinoma 9 Adenocarcinoma Of Esophagus 8 Uterine Cervical Neoplasms 7 Glioma 7 Triple Negative Breast Neoplasms 6 Stomach Neoplasms 6 Gliosarcoma 6 Carcinoma, Squamous Cell 6 Brain Neoplasms 6 Urinary Bladder Neoplasms 5 Nasopharyngeal Carcinoma 5 Melanoma 5 Laryngeal Neoplasms 5 Colorectal Neoplasms 5 Xerostomia 4 Sarcoma 4 Mouth Neoplasms 4

Interventions

AZD 6244 9 trametinib 3 mirdametinib 3 Lovastatin 3 Sirolimus 2 Inhalation 2 Everolimus 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 pirfenidone 1 peginterferon alfa-2b 1 omipalisib 1 fludarabine 1 cediranib 1 binimetinib 1 Vitamin D 1 Vincristine 1 Vinblastine 1 Temozolomide 1 Sunitinib 1 Saline Solution 1 Rituximab 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Methotrexate 1 Melphalan 1 Levetiracetam 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡